ホーム > 塩澤 利博/ Shiozawa, Toshihiro

塩澤 利博

Shiozawa, Toshihiro

医学医療系 , 講師
Institute of Medicine , Assistant Professor

To understand the complexity and heterogeneity of chronic inflammatory lung diseases　to achieve preemptive medicine and precision medicine. | 檜澤 伸之 | 筑波大学研究者カタログ

2021-04-25

檜澤 伸之 佐藤 浩昭 石井 幸雄 坂本 透 籠橋 克紀 山田 英恵 松野 洋輔 際本 拓未 増子 裕典 中澤 健介 塩澤 利博
オープンアクセス版の論文は「つくばリポジトリ」で読むことができます。
  1. 1. Dose Reduction of EGFR-TKIs for EGFR-positive Non-small Cell Lung Cancer: A Retrospective Study Mochizuki, Akira; Matsumoto, Hiroaki; Maezawa, Yosuke; Okauchi, Shinichiro (+7 著者) Hizawa, Nobuyuki
      Cancer diagnosis & prognosis 5: 207 (2025)
  2. 2. Outcomes of Combined Atezolizumab Plus Chemotherapy in Non-small Cell Lung Cancer Patients in Clinical Practice Numata, Takeshi; Nakamura, Ryota; Shiozawa, Toshihiro; Watanabe, Hiroko (+12 著者) Hizawa, Nobuyuki
      Cancer diagnosis & prognosis 5: 105 (2025)
  3. 3. Age and smoking intensity in non-small cell lung cancer patients with the anaplastic lymphoma kinase fusion gene Maezawa, Yosuke; Taguchi, Manato; Kawakami, Takeshi; Inui, Toshihide (+9 著者) Hizawa, Nobuyuki
      Contemporary oncology (Poznan, Poland) 29: 93 (2025)
  4. 4. Prognostic Factors for Patients with Small-Cell Lung Cancer Treated with Chemoimmunotherapy: A Retrospective Multicenter Study Hatori, Takashi; Numata, Takeshi; Shiozawa, Toshihiro; Taguchi, Manato (+9 著者) Hizawa, Nobuyuki
      CURRENT ONCOLOGY 31: 6502 (2024)
  5. 5. Novel therapeutic strategies targeting bypass pathways and mitochondrial dysfunction to combat resistance to RET inhibitors in NSCLC Shiba-Ishii, Aya; Isagawa, Takayuki; Shiozawa, Toshihiro; Mato, Naoko (+8 著者) Matsubara, Daisuke
      BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE 1870: (2024) Semantic Scholar
  6. 6. Real Clinical Practice of Combined Atezolizumab Plus Chemotherapy in Patients With Small Cell Lung Cancer Ano, Satoshi; Kikuchi, Norihiro; Okauchi, Shinichiro; Numata, Takeshi (+12 著者) Hizawa, Nobuyuki
      ANTICANCER RESEARCH 44: 2725 (2024) Semantic Scholar
  7. 7. Investigation of age and smoking in NSCLC patients with uncommon EGFR mutations Maezawa, Yosuke; Taguchi, Manato; Kawakami, Takeshi; Inui, Toshihide (+9 著者) Hizawa, Nobuyuki
      TUBERKULOZ VE TORAKS-TUBERCULOSIS AND THORAX 72: 107 (2024)
  8. 8. Patient Age and EGFR-positive Non-small Cell Lung Cancer: A Multicenter Retrospective Study Maezawa, Yosuke; Taguchi, Manato; Kawakami, Takeshi; Inui, Toshihide (+9 著者) Hizawa, Nobuyuki
      ANTICANCER RESEARCH 44: 1751 (2024)
  9. 9. 両側主肺動脈狭窄をきたした胸腺癌に対して化学放射線療法が奏功した1例 木村, 浩樹; 中川, 龍星; 北澤, 晴奈; 渡邊, 安祐美 (+13 著者) 檜澤, 伸之
      日本結核・非結核性抗酸菌症学会関東支部学会・日本呼吸器学会関東地方会合同学会プログラム・抄録集 185回・258回: 22 (2024)
  10. 10. Extended ICI treatment after first-line chemoimmunotherapy could predict the clinical benefit of ramucirumab plus docetaxel in advanced non-small lung cancer: Post hoc analysis from NEJ051 (REACTIVE study) Yamaguchi, Ou; Mori, Keita; Takata, Saori; Shibata, Kazuhiko (+13 著者) Kaira, Kyoichi
      THORACIC CANCER 15: 163 (2023) Semantic Scholar
  11. 11. Atezolizumab for EGFR-mutated Non-small Cell Lung Cancer Patients: An Observation Study in Ibaraki Group (ATTENTION-IBARAKI) Tamura, Tomohiro; Numata, Takeshi; Yanai, Hidetoshi; Nakamura, Ryota (+14 著者) Hizawa, Nobuyuki
      ANTICANCER RESEARCH 43: 4583 (2023) Semantic Scholar
  12. 12. Atezolizumab Monotherapy for Non-small Cell Lung Cancer Patients: An Observational Study in Ibaraki Group (ATTENTION-IBARAKI) Okauchi, Shinichiro; Ohara, Gen; Shiozawa, Toshihiro; Watanabe, Hiroko (+15 著者) Hizawa, Nobuyuki
      IN VIVO 37: 2203 (2023)
  13. 13. アレクチニブが奏功したALK陽性肺腺癌、脈絡膜転移の一例 脈絡膜転移を考察する 木下, 侑亮; 阿部, 優; 増子, 裕典; 上田, 航大 (+13 著者) 檜澤, 伸之
      日本結核・非結核性抗酸菌症学会関東支部学会・日本呼吸器学会関東地方会合同学会プログラム・抄録集 184回・256回: 23 (2023)
  14. 14. Long-term Progression-free Survival With Pemetrexed Plus Bevacizumab in NSCLC Patients Hayashi, Shigen; Miyazaki, Kunihiko; Shiozawa, Toshihiro; Okauchi, Shinichiro (+4 著者) Hizawa, Nobuyuki
      Cancer diagnosis & prognosis 3: 377 (2023) Semantic Scholar
  15. 15. NSCLC Patients Achieving Long-term Progression-free Survival With Docetaxel Plus Ramucirumab: A Retrospective Study Miyazaki, Kunihiko; Shiozawa, Toshihiro; Okauchi, Shinichiro; Sakurai, Hirofumi (+1 著者) Hizawa, Nobuyuki
      Cancer diagnosis & prognosis 3: 215 (2023) Semantic Scholar
  16. 16. Relationship Between TTF-1 Expression and PFS of Pemetrexed-containing Chemotherapy in Non-squamous-NSCLC Patients With and Without Driver Genes Okauchi, Shinichiro; Miyazaki, Kunihiko; Shiozawa, Toshihiro; Satoh, HiroakiHizawa, Nobuyuki
      Cancer diagnosis & prognosis 3: 53 (2023) Semantic Scholar
  17. 17. Discontinuation of Immune Checkpoint Inhibitor due to irAEs in NSCLC Patients With EGFR Mutation Okauchi, Shinichiro; Miyazaki, Kunihiko; Shiozawa, Toshihiro; Yamada, Hideyasu (+1 著者) Hizawa, Nobuyuki
      Cancer diagnosis & prognosis 3: 244 (2023) Semantic Scholar
  18. 18. Discontinuation of Immune Checkpoint Inhibitor due to irAEs in NSCLC Patients With EGFR Mutation Okauchi, Shinichiro; Miyazaki, Kunihiko; Shiozawa, Toshihiro; Yamada, Hideyasu (+1 著者) Hizawa, Nobuyuki
      Cancer diagnosis & prognosis 3: 244 (2023) Semantic Scholar
  19. 19. Effects of lymphopenia on survival in proton therapy with chemotherapy for non-small cell lung cancer. Masatoshi Nakamura; Hitoshi Ishikawa; Kayoko Ohnishi; Yutarou Mori (+6 著者) Hideyuki Sakurai
      Journal of radiation research (2023) Semantic Scholar
  20. 20. Discontinuation of Immune Checkpoint Inhibitor and Survival in Patients With Non-small-cell Lung Cancer Without a Driver Gene Mutation Hattori, Sou; Okauchi, Shinichiro; Sasatani, Yuika; Ohara, Gen (+5 著者) Hizawa, Nobuyuki
      ANTICANCER RESEARCH 42: 4589 (2022) Semantic Scholar
1 2 3 … 5
  1. 1. Annual Review 呼吸器 2011年 塩澤利博; 大江裕一郎
    中外医薬社 2011年1月

 1,127 total views